Insulin, islet amyloid polypeptide and C-peptide interactions evaluated by mass spectrometric analysis

Rapid Communications in Mass Spectrometry

Volumn 28, Issue 2, 2014, Pages 178-184

  Landreh, Michael ^a   Alvelius, Gunvor ^a   Johansson, Jan ^a,b   Jörnvall, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ASSOCIATION REACTIONS; DISSOCIATION; ELECTROSPRAY IONIZATION; GLYCOPROTEINS; HYDROPHOBICITY; INSULIN; IONIZATION OF GASES; MASS SPECTROMETRY; POLYPEPTIDES;

COMPLEX FORMATIONS; DEVELOPMENT STRATEGIES; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; ISLET AMYLOID POLYPEPTIDES; MASS SPECTROMETRIC ANALYSIS; PANCREATIC BETA CELLS; PEPTIDE AGGREGATION; PEPTIDE COMPLEX; PROINSULIN; SEQUENCE DETERMINANTS;

PEPTIDES;

AMYLIN; C PEPTIDE; INSULIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMISTRY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN ANALYSIS; PROTEIN MULTIMERIZATION;

AMINO ACID SEQUENCE; BINDING SITES; C-PEPTIDE; HUMANS; INSULIN; ISLET AMYLOID POLYPEPTIDE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION;

EID: 84890531171     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6772     Document Type: Article

References (32)

1. D. J. Michael, H. Cai, W. Xiong, J. Ouyang, R. H. Chow,. Mechanisms of peptide hormone secretion. Trends Endocrinol. Metab. 2006, 17, 408.
2. H. W. Davidson, C. J. Rhodes, J. C. Hutton,. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 1988, 333, 93.
3. J. Suckale, M. Solimena,. The insulin secretory granule as a signaling hub. Trends Endocrinol. Metab. 2010, 21, 599.
4. P. Westermark, A. Andersson, G. T. Westermark,. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 2011, 91, 795.
5. L. M. Yan, M. Tatarek-Nossol, A. Velkova, A. Kazantzis, A. Kapurniotu,. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc. Natl. Acad. Sci. USA 2006, 103, 2046.
6. F. E. Dische, C. Wernstedt, G. T. Westermark, P. Westermark, M. B. Pepys, J. A. Rennie, S. G. Gilbey, P. J. Watkins,. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988, 31, 158.
7. M. Landreh, J. Johansson, H. Jornvall,. C-peptide: a molecule balancing insulin states in secretion and diabetes-associated depository conditions. Horm. Metab. Res. 2013, 45, 769.
8. R. P. Nanga, J. R. Brender, J. Xu, G. Veglia, A. Ramamoorthy,. Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry 2008, 47, 12689.
9. J. J. Wiltzius, S. A. Sievers, M. R. Sawaya, D. Eisenberg,. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci. 2009, 18, 1521.
10. N. F. Dupuis, C. Wu, J. E. Shea, M. T. Bowers,. The amyloid formation mechanism in human IAPP: dimers have beta-strand monomer-monomer interfaces. J. Am. Chem. Soc. 2011, 133, 7240.
11. J. L. Larson, A. D. Miranker,. The mechanism of insulin action on islet amyloid polypeptide fiber formation. J. Mol. Biol. 2004, 335, 221.
12. L. Wei, P. Jiang, Y. H. Yau, H. Summer, S. G. Shochat, Y. Mu, K. Pervushin,. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin. Biochemistry 2009, 48, 2368.
13. C. E. Munte, L. Vilela, H. R. Kalbitzer, R. C. Garratt,. Solution structure of human proinsulin C-peptide. FEBS J. 2005, 272, 4284.
14. S. Janciauskiene, S. Eriksson, E. Carlemalm, B. Ahren,. B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem. Biophys. Res. Commun. 1997, 236, 580.
15. P. Westermark, Z. C. Li, G. T. Westermark, A. Leckstrom, D. F. Steiner,. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 1996, 379, 203.
16. J. Lind, E. Lindahl, A. Peralvarez-Marin, A. Holmlund, H. Jornvall, L. Maler,. Structural features of proinsulin C-peptide oligomeric and amyloid states. FEBS J. 2010, 277, 3759.
17. H. Jornvall, E. Lindahl, J. Astorga-Wells, J. Lind, A. Holmlund, E. Melles, G. Alvelius, C. Nerelius, L. Maler, J. Johansson,. Oligomerization and insulin interactions of proinsulin C-peptide: Threefold relationships to properties of insulin. Biochem. Biophys. Res. Commun. 2010, 391, 1561.
18. L. Nielsen, R. Khurana, A. Coats, S. Frokjaer, J. Brange, S. Vyas, V. N. Uversky, A. L. Fink,. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001, 40, 6036.
19. Q. X. Hua, M. A. Weiss,. Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J. Biol. Chem. 2004, 279, 21449.
20. M. I. Ivanova, S. A. Sievers, M. R. Sawaya, J. S. Wall, D. Eisenberg,. Molecular basis for insulin fibril assembly. Proc. Natl. Acad. Sci. USA 2009, 106, 18990.
21. J. Marcoux, C. V. Robinson,. Twenty years of gas phase structural biology. Structure 2013, 21, 1541.
22. D. M. Williams, T. L. Pukala,. Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry. Mass Spectrom. Rev. 2013, 32, 169.
23. M. Landreh, J. Astorga-Wells, J. Johansson, T. Bergman, H. Jornvall,. New developments in protein structure-function analysis by MS and use of hydrogen-deuterium exchange microfluidics. FEBS J. 2011, 278, 3815.
24. E. J. Nettleton, P. Tito, M. Sunde, M. Bouchard, C. M. Dobson, C. V. Robinson,. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 2000, 79, 1053.
25. J. Shafqat, E. Melles, K. Sigmundsson, B. L. Johansson, K. Ekberg, G. Alvelius, M. Henriksson, J. Johansson, J. Wahren, H. Jornvall,. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell. Mol. Life Sci. 2006, 63, 1805.
26. M. Landreh, J. B. Stukenborg, H. Willander, O. Soder, J. Johansson, H. Jornvall,. Proinsulin C-peptide interferes with insulin fibril formation. Biochem. Biophys. Res. Commun. 2012, 418, 489.
27. M. Landreh, G. Alvelius, H. Willander, J. B. Stukenborg, O. Soder, J. Johansson, H. Jornvall,. Insulin solubility transitions by pH-dependent interactions with proinsulin C-peptide. FEBS J. 2012, 279, 4589.
28. J. L. Larson, E. Ko, A. D. Miranker,. Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry. Protein Sci. 2000, 9, 427.
29. J. M. Daniel, S. D. Friess, S. Rajagopalan, S. Wendt, R. Zenobi,. Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry. Int. J. Mass Spectrom. 2002, 216, 1.
30. N. F. Dupuis, C. Wu, J. E. Shea, M. T. Bowers,. Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. J. Am. Chem. Soc. 2009, 131, 18283.
31. K. Breuker, F. W. McLafferty,. Stepwise evolution of protein native structure with electrospray into the gas phase, 10(-12) to 10(2) s. Proc. Natl. Acad. Sci. USA 2008, 105, 18145.
32. S. Gilead, H. Wolfenson, E. Gazit,. Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin. Angew. Chem. Int. Ed. Engl. 2006, 45, 6476.